<p>根据 Blue Trust Inc.在最近向证券交易委员会提交的 13F 表格，该公司在第三季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的持仓降低了 11.1%。该公司在此期间出售了 3,294 股后，持有 26,384 股 HCA 的股票。根据其最近向证券交易委员会的提交，Blue Trust Inc.在 HCA Healthcare 的持股价值为 11,245,000 美元。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
<p>其他几家大型投资者最近也买卖了 HCA 的股票。挪威银行在第二季度购买了 HCA Healthcare 的新头寸，价值约为 1,152,408,000 美元。Viking Global Investors LP 在第二季度将其在 HCA Healthcare 的持仓提高了 58.5%。Viking Global Investors LP 现在拥有 1,872,133 股该公司的股票，价值 717,214,000 美元，此前在此期间又购买了 690,773 股。Nordea Investment Management AB 在第二季度将其在 HCA Healthcare 的股份增加了 6.8%。Nordea Investment Management AB 现在拥有 927,781 股该公司的股票，价值 350,404,000 美元，此前又购买了 59,163 股。Pacer Advisors Inc.在第三季度将其在 HCA Healthcare 的持仓提高了 6,115.3%。Pacer Advisors Inc.现在拥有 911,096 股该公司的股票，价值 388,309,000 美元，此前在上个季度又购买了 896,437 股。最后，LSV Asset Management 在第二季度将其在 HCA Healthcare 的股份增加了 0.4%。LSV Asset Management 现在拥有 868,849 股该公司的股票，价值 332,856,000 美元，此前在上个季度又购买了 3,396 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
<h2>分析师评级变动</h2>
<p>一些分析师最近对 HCA 股票发表了看法。Raymond James Financial 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价设定为 525.00 美元。Oppenheimer 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 400.00 美元提高到 500.00 美元，并给予该股票 “跑赢大盘” 的评级。Wells Fargo &amp; Company 在 11 月 13 日的研究报告中将 HCA Healthcare 的目标价从 412.00 美元提高到 431.00 美元，并给予该公司 “持平” 的评级。美国银行在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 430.00 美元提高到 470.00 美元，并给予该股票 “中性” 的评级。最后，Zacks Research 在 11 月 27 日的研究报告中将 HCA Healthcare 的评级从 “强力买入” 下调至 “持有”。十四位股票研究分析师对该股票给予了买入评级，九位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，HCA Healthcare 目前的共识评级为 “适度买入”，共识目标价为 479.00 美元。</p>
<ul>
<li>HCA Healthcare 能否振兴市场上最疲软的行业？</li>
</ul>
<p><strong>阅读我们关于 HCA 的最新股票报告</strong></p>
<h2>HCA Healthcare 的内部买卖</h2>
<p>在其他新闻中，执行副总裁 Michael R. Mcalevey 在 11 月 5 日的交易中出售了 3,892 股该公司的股票。该股票以 473.79 美元的平均价格出售，总价值为 1,843,990.68 美元。交易后，该执行副总裁直接持有 3,487 股公司股票，价值 1,652,105.73 美元。这笔交易代表了其持仓的 52.74% 的减少。该交易已在向证券交易委员会提交的文件中披露，文件可在此链接查看。公司内部人士目前持有 1.30% 的股票。</p>
<h2>HCA Healthcare 交易上涨 0.0%</h2>
<ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
<p>HCA 的股票在周五以 474.06 美元开盘。HCA Healthcare, Inc.的 1 年最低价为 289.98 美元，1 年最高价为 520.00 美元。该公司的 50 日移动平均线为 474.62 美元，200 日移动平均线为 419.32 美元。该公司的市值为 1,081.8 亿美元，市盈率为 18.32，市盈增长比率为 1.40，贝塔系数为 1.36。</p>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近在 10 月 24 日公布了季度财报。该公司报告本季度每股收益为 6.96 美元，超出分析师的共识预期 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的股本回报率为负的 792.25%，净利润率为 8.53%。该公司本季度的收入为 191.6 亿美元，而分析师的预期为 185.5 亿美元。在去年同期，该公司的每股收益为 4.90 美元。与去年同期相比，该公司的收入增长了 9.6%。HCA Healthcare 已将其 2025 财年的指导目标设定为 27.000-28.000 每股收益。平均而言，卖方分析师预测 HCA Healthcare, Inc.在当前年度将发布 24.98 每股收益。</p>
<h2>HCA Healthcare 宣布分红</h2>
<p>该公司最近还披露了一项季度分红，将于 12 月 29 日支付。12 月 15 日的登记投资者将获得 0.72 美元的分红。这相当于每年 2.88 美元的分红，收益率为 0.6%。除息日期为 12 月 15 日。HCA Healthcare 的分红支付比率（DPR）目前为 11.13%。</p>
<h2>HCA Healthcare 简介</h2>
<p>（免费报告）</p>
<p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
<p>公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 HCA Healthcare 更好的股票</li>
<li>在 1 月 1 日前投资$1,000 于这只股票 [不是 NVDA]</li>
<li>将你的 “死钱” 转变为每月$306+（从这个月开始）</li>
<li>华盛顿准备战争</li>
<li>奇怪的水晶金属性能超过硅达 100 倍</li>
<li>来自奇怪的新 “AI 燃料” 的 33,000% 繁荣？</li>
</ul>
<p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 HCA Healthcare, Inc.（NYSE:HCA - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 于 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

<p>Blue Trust Inc. 在第三季度减少了对 HCA Healthcare 的持股比例，降幅为 11.1%，目前持有 26,384 股，市值为 1120 万美元。分析师的评级各不相同，但普遍共识为 “适度买入”，目标价为 479.00 美元。HCA 的股票开盘价为 474.06 美元，过去一年股价区间为 289.98-520.00 美元。该公司报告第三季度每股收益为 6.96 美元，超出预期，收入同比增长 9.6%，达到 191.6 亿美元</p>

<p>Blue Trust Inc. lowered its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 26,384 shares of the company's stock after selling 3,294 shares during the period. Blue Trust Inc.'s holdings in HCA Healthcare were worth $11,245,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>根据 Blue Trust Inc.在最近向证券交易委员会提交的 13F 表格，该公司在第三季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的持仓降低了 11.1%。该公司在此期间出售了 3,294 股后，持有 26,384 股 HCA 的股票。根据其最近向证券交易委员会的提交，Blue Trust Inc.在 HCA Healthcare 的持股价值为 11,245,000 美元。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 07/28 - 08/01</li>
</ul>
</div><p>Several other large investors also recently bought and sold shares of HCA. Norges Bank purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB increased its stake in HCA Healthcare by 6.8% during the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company's stock worth $350,404,000 after buying an additional 59,163 shares during the period. Pacer Advisors Inc. raised its position in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company's stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter. Finally, LSV Asset Management grew its stake in HCA Healthcare by 0.4% in the second quarter. LSV Asset Management now owns 868,849 shares of the company's stock worth $332,856,000 after purchasing an additional 3,396 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他几家大型投资者最近也买卖了 HCA 的股票。挪威银行在第二季度购买了 HCA Healthcare 的新头寸，价值约为 1,152,408,000 美元。Viking Global Investors LP 在第二季度将其在 HCA Healthcare 的持仓提高了 58.5%。Viking Global Investors LP 现在拥有 1,872,133 股该公司的股票，价值 717,214,000 美元，此前在此期间又购买了 690,773 股。Nordea Investment Management AB 在第二季度将其在 HCA Healthcare 的股份增加了 6.8%。Nordea Investment Management AB 现在拥有 927,781 股该公司的股票，价值 350,404,000 美元，此前又购买了 59,163 股。Pacer Advisors Inc.在第三季度将其在 HCA Healthcare 的持仓提高了 6,115.3%。Pacer Advisors Inc.现在拥有 911,096 股该公司的股票，价值 388,309,000 美元，此前在上个季度又购买了 896,437 股。最后，LSV Asset Management 在第二季度将其在 HCA Healthcare 的股份增加了 0.4%。LSV Asset Management 现在拥有 868,849 股该公司的股票，价值 332,856,000 美元，此前在上个季度又购买了 3,396 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of analysts have recently weighed in on HCA shares. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an &#34;outperform&#34; rating in a research report on Monday, October 27th. Wells Fargo &amp; Company raised their target price on HCA Healthcare from $412.00 to $431.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, November 13th. Bank of America lifted their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a &#34;neutral&#34; rating in a research note on Monday, October 27th. Finally, Zacks Research lowered shares of HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $479.00.</p>
<div class="lb-trans"><p>一些分析师最近对 HCA 股票发表了看法。Raymond James Financial 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价设定为 525.00 美元。Oppenheimer 在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 400.00 美元提高到 500.00 美元，并给予该股票 “跑赢大盘” 的评级。Wells Fargo &amp; Company 在 11 月 13 日的研究报告中将 HCA Healthcare 的目标价从 412.00 美元提高到 431.00 美元，并给予该公司 “持平” 的评级。美国银行在 10 月 27 日的研究报告中将 HCA Healthcare 的目标价从 430.00 美元提高到 470.00 美元，并给予该股票 “中性” 的评级。最后，Zacks Research 在 11 月 27 日的研究报告中将 HCA Healthcare 的评级从 “强力买入” 下调至 “持有”。十四位股票研究分析师对该股票给予了买入评级，九位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，HCA Healthcare 目前的共识评级为 “适度买入”，共识目标价为 479.00 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振兴市场上最疲软的行业？</li>
</ul>
</div><p><strong>Read Our Latest Stock Report on HCA</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 HCA 的最新股票报告</strong></p>
</div><h2>Insider Buying and Selling at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的内部买卖</h2>
</div><p>In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm's stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，执行副总裁 Michael R. Mcalevey 在 11 月 5 日的交易中出售了 3,892 股该公司的股票。该股票以 473.79 美元的平均价格出售，总价值为 1,843,990.68 美元。交易后，该执行副总裁直接持有 3,487 股公司股票，价值 1,652,105.73 美元。这笔交易代表了其持仓的 52.74% 的减少。该交易已在向证券交易委员会提交的文件中披露，文件可在此链接查看。公司内部人士目前持有 1.30% 的股票。</p>
</div><h2>HCA Healthcare Trading Up 0.0%</h2>
<div class="lb-trans"><h2>HCA Healthcare 交易上涨 0.0%</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
</div><p>Shares of NYSE:HCA opened at $474.06 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The business's 50 day moving average is $474.62 and its 200-day moving average is $419.32. The firm has a market capitalization of $108.18 billion, a PE ratio of 18.32, a PEG ratio of 1.40 and a beta of 1.36.</p>
<div class="lb-trans"><p>HCA 的股票在周五以 474.06 美元开盘。HCA Healthcare, Inc.的 1 年最低价为 289.98 美元，1 年最高价为 520.00 美元。该公司的 50 日移动平均线为 474.62 美元，200 日移动平均线为 419.32 美元。该公司的市值为 1,081.8 亿美元，市盈率为 18.32，市盈增长比率为 1.40，贝塔系数为 1.36。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts' expectations of $18.55 billion. During the same period in the prior year, the business posted $4.90 earnings per share. The business's revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近在 10 月 24 日公布了季度财报。该公司报告本季度每股收益为 6.96 美元，超出分析师的共识预期 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的股本回报率为负的 792.25%，净利润率为 8.53%。该公司本季度的收入为 191.6 亿美元，而分析师的预期为 185.5 亿美元。在去年同期，该公司的每股收益为 4.90 美元。与去年同期相比，该公司的收入增长了 9.6%。HCA Healthcare 已将其 2025 财年的指导目标设定为 27.000-28.000 每股收益。平均而言，卖方分析师预测 HCA Healthcare, Inc.在当前年度将发布 24.98 每股收益。</p>
</div><h2>HCA Healthcare Announces Dividend</h2>
<div class="lb-trans"><h2>HCA Healthcare 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.13%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度分红，将于 12 月 29 日支付。12 月 15 日的登记投资者将获得 0.72 美元的分红。这相当于每年 2.88 美元的分红，收益率为 0.6%。除息日期为 12 月 15 日。HCA Healthcare 的分红支付比率（DPR）目前为 11.13%。</p>
</div><h2>HCA Healthcare Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li>
<li>Washington prepares for war</li>
<li>Strange Crystal Metal Outperforms Silicon Up to 100X</li>
<li>33,000% boom from weird new “AI Fuel?”</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 HCA Healthcare 更好的股票</li>
<li>在 1 月 1 日前投资$1,000 于这只股票 [不是 NVDA]</li>
<li>将你的 “死钱” 转变为每月$306+（从这个月开始）</li>
<li>华盛顿准备战争</li>
<li>奇怪的水晶金属性能超过硅达 100 倍</li>
<li>来自奇怪的新 “AI 燃料” 的 33,000% 繁荣？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 HCA Healthcare, Inc.（NYSE:HCA - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 于 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Blue Trust Inc. 减少了其在 HCA Healthcare, Inc. $HCA 的股票持仓